Effect of Bromocriptine-QR (a Quick-Release Formulation of Bromocriptine Mesylate) on Major Adverse Cardiovascular Events in Type 2 Diabetes Subjects

por Gaziano, J. Michael, Cincotta, Anthony H., Vinik, Aaron, Blonde, Lawrence, Bohannon, Nancy, Scranton, Richard
Publicado 2012

Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release

por Garvey, W. Timothy, Ryan, Donna H., Henry, Robert, Bohannon, Nancy J.V., Toplak, Hermann, Schwiers, Michael, Troupin, Barbara, Day, Wesley W.
Publicado 2014